BioRestorative Therapies, Inc. - BRTX

Sector: Healthcare · Industry: Biotechnology
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$378K
QoQ value delta ($000)
-$167K (-30.64%)
Implied price effect (QoQ)
-19.53%
Shares
Total shares
327,174
QoQ shares delta
-52,409 (-13.81%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (BRTX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 23 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 103 88,778 0.0%
GEODE CAPITAL MANAGEMENT, LLC 67 57,854 0.0%
DRW Securities, LLC 54 46,665 0.0%
WEALTH ALLIANCE, LLC 47 40,000 0.0%
STATE STREET CORP 37 32,459 0.0%
CITADEL ADVISORS LLC 34 29,198 0.0%
Napier Financial, LLC 20 17,142 0.0%
TWO SIGMA SECURITIES, LLC 13 11,777 0.0%
OSAIC HOLDINGS, INC. 2 2,000 0.0%
Tower Research Capital LLC (TRC) 1 1,106 0.0%
BANK OF AMERICA CORP /DE/ 0 60 0.0%
Parallel Advisors, LLC 0 1 0.0%
Cornerstone Planning Group LLC 0 1 0.0%
SBI Securities Co., Ltd. 0 119 0.0%
TD Waterhouse Canada Inc. 0 3 0.0%
Rossby Financial, LCC 0 11 0.0%